MESULID AMSOLIDE NIMEROL NIMEROL PENSULIDE NIMSEL MELIDE NIDOL ARTILIDE COX-2 GEOSLIDE SULIDE-100 UNIX SLIDE NUGESIC NUGESIC NUGESIC NARCOGEN NOACH NO-ACH LEMIDE ERIC NICOX NIMARAN NIMESOTA NIROX COXOBID NISE RHEUSLIDE ANALID RAKALIDE MODACT-IR GRAVX WULID NIMS LEDOREN MEXIDON ARSLIDE ORINA NIMCID BLUNID ENIM MUSIDE NIMASE NIMSULID NIMBEX-100 NIIGIX NIMCOX PAIN-AID OMINOX NEOLIDE NELSID OSTEOSOFT ZULIDE FENSULID FENSULID NIMOLIVE LIDE NIMVISTA ALSOLIDE ORTHOSULIDE NIMSIDE NIMEPAN FRENDCOGEN EXILIDE NULIDE COLWAY NIMEX NEMSIS MARICOX

Dose: 0 to 100 mg
Single Dose: 50 (50)
Frequency: 12 hourly
Route: PO
Instructions: Increase upto 200mg bid.

Dose:
Single Dose:
Frequency:
Route:
Instructions: Not recommended in this age group

Dose:
Single Dose:
Frequency:
Route:
Instructions: Not recommended in this age group

. It is of Synthetic origin and belongs to Sulphon Anilide. It belongs to Cyclo-oxygenase inhibitor pharmacological group on the basis of mechanism of action and also classified in Analgesics and Anti-inflammatory Agents pharmacological group.The Molecular Weight of Nimesulide is 308.30.

Nimesulide is contraindicated in conditions like GI ulceration,GI hemorrhage.

The severe or irreversible adverse effects of Nimesulide, which give rise to further complications include Stevens johnson syndrome, lyells syndrome, hepatoxicity.Nimesulide produces potentially life-threatening effects which include Anaphylaxis. which are responsible for the discontinuation of Nimesulide therapy.The signs and symptoms that are produced after the acute overdosage of Nimesulide include Hypotension, Hypothermia.The symptomatic adverse reactions produced by Nimesulide are more or less tolerable and if they become severe, they can be treated symptomatically, these include Headache, Drowsiness, Nausea, Pain, VertigoX, Thrombocytopenia, Melena.

Nimesulide is primarily indicated in conditions like Bursitis, Fever, fever, Gynecological infections, Inflammation, Osteoarthritis, Pain, Rheumatoid arthritis, Tendinitis, Thrombophlebitis, Trauma, and can also be given in adjunctive therapy as an alternative drug of choice in Ent infections.

No data regarding the interactions of Nimesulide was found.

Drug should not be given to Pregnant Mothers, and Geriatrics.If prescribing authority justifies the benefits of the drug against the possible damages he/she should reevaluate them and consult the reference material and previous studies.

Nimesulide must be used with care among patients with a history of bleeding, with illnesses of the upper gastrointestinal tract and to subjects undergoing treatment with anticoagulants or drugs that inhibit platelet aggregation. The patients must be under direct medical supervision while taking substances with limited gastric tolerance at the same time. Since the drug is eliminated mainly through the kidneys, patient with the renal insufficiency must have a lower dosage depending on the glomerular filtration rate. The product must not be administered to the patient with severe renal insufficiency. The product can cause water retention, therefore it must not be administered to the patient with reduced cardiac function. Patients whose activity require alertness must take the product with care in case they notice drowsiness or vertigo during therapy . Cases of visual disturbances when using other non-steroidal anti-inflammatory drugs have been reported, If eye problems appear, the treatment must be interrupted and an eye examination must be performed.